Ambience Healthcare
ConvictionContext
B2B enterprise SaaS; per-provider annual contracts (per clinical FTE), land-and-expand into health systems, tiered by module suite
Revenue
~$30M ARRMay 2025, secondary/estimated per Sacra; not company-auditedRev growth
~58%$19M ARR end-2024 -> ~$30M May 2025, estimatedGross margin
not disclosedprivate; typically 60-75% for enterprise health-IT SaaS but unverified for Ambience given LLM inference COGSOp margin
not disclosed - presumed deeply negativegrowth-stage, scaling GTMCapex intensity
not disclosed - asset-light softwareprimary spend is R&D + cloud/model inference (opex, not capexValuation
~$1.25BSeries C, Jul 2025; Sacra cites ~$1B on the same roundValuation trail
$1.25B9.9× since 2022
3 marks · 2022–Jul 2025
private — no public price
Priced round Secondary / SPAC mark
The Series B ($70M, Feb 2024, co-led by Kleiner Perkins & OpenAI Startup Fund) post-money valuation was not publicly disclosed, so no point is plotted for it. The only firmly disclosed round valuation is the Jul-2025 Series C at ~$1.25B; the 2022 Series A mark is a PitchBook estimate and Sacra's ~$1B is a secondary-market estimate of the same Series C round.
The read
Where our coverage leans
Bull & bear in tension
Sign in to read the bull & bear take — Pro unlocks the full dossier.
Members only
Full financial intelligence for Ambience Healthcare
Earnings, margins & COGS, the income-statement breakdown, SWOT, moats & dependencies, the supplier–customer ecosystem graph, top signals & trends, and the valuation range.
- Income statement & margin structure
- SWOT, moats & dependency map
- Supplier–customer ecosystem graph
- Signals, trends & valuation range
Not investment advice — analyst work product for a qualified professional.· intel vintage 2026-07· sign in (free) for the analyst summary; Pro unlocks full intelligence